Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diseases and drug protein binding.

J P Tillement, F Lhoste, J F Giudicelli

    Clinical Pharmacokinetics
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Pathological states can decrease drug plasma protein binding, affecting drug efficacy and requiring therapeutic adjustments. Further research is needed to determine optimal drug dosage and plasma protein correction strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [8th Descartes-Berkeley interuniversity symposium on health economics, May 2013, Paris, France: an overview].

    Annales pharmaceutiques francaises·2013
    Same author

    [Trust-based economics with medicine outcome-based pricing].

    Annales pharmaceutiques francaises·2013
    Same author

    Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2005
    Same author

    Coronary dilatation reserve in experimental hypertension and chronic heart failure: effects of blockade of the renin-angiotensin system.

    Clinical and experimental pharmacology & physiology·2002
    Same author

    Pharmacological delayed preconditioning against ischaemia-induced ventricular arrhythmias: effect of an adenosine A(1)-receptor agonist.

    British journal of pharmacology·2001
    Same author

    Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.

    The Journal of pharmacology and experimental therapeutics·2001

    Area of Science:

    • Pharmacology
    • Clinical Chemistry

    Background:

    • Decreased plasma protein binding of drugs occurs in various pathological states.
    • Factors influencing binding include protein characteristics, drug properties, and binding conditions.
    • Key conditions involve hypoalbuminemia, altered albumin volume, and pathological inhibitors.

    Purpose of the Study:

    • To investigate the clinical significance of reduced drug plasma protein binding.
    • To address therapeutic questions regarding drug dosage and plasma protein correction.

    Main Methods:

    • Analysis of factors affecting drug-protein interactions in disease states.
    • Evaluation of the impact of reduced binding on drug effects.
    • Consideration of therapeutic strategies for managing altered binding.

    Related Experiment Videos

    Main Results:

    • Reduced drug plasma protein binding does not always result in enhanced drug effects.
    • The clinical significance of decreased binding requires careful therapeutic consideration.

    Conclusions:

    • Reduced drug plasma protein binding presents therapeutic challenges.
    • Tentative answers exist for managing drug dosage and plasma protein levels, but further investigation is warranted.